Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion type Assertion NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_head.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion description "[We found that carriers of the CYP2E1*5 variant were at 2.8-fold higher risk of ALL (95%CI, 1.2-6.4) and that NQO1 alleles *2 and *3 contributed to the risk of ALL as well (OR = 1.7, 95%CI, 1.2-2.4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_provenance.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion evidence source_evidence_literature NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_provenance.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion SIO_000772 11774269 NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_provenance.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion wasDerivedFrom befree-20140225 NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_provenance.
- NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_assertion wasGeneratedBy ECO_0000203 NP680049.RA2jiQpNQN-glVhK8MLZox09GVFwyZc50ijtVytroVoJg130_provenance.